Company profile CABA

Cabaletta Bio Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 17:51:20.

After 39 days of this quarter the interest is at 158.0. Based on that we can calculate that during remaining 52 days it will total up to 369.0.
Cabaletta Bio expected interest is significantly higher compared to same quarter last year (+70.8%) but similar to previous quarter.

YearQ1Q2Q3Q4
201944
90
104.5% QoQ
68
-24.4% QoQ
155
127.9% QoQ
2020 154
250.0% YoY -0.6% QoQ
127
41.1% YoY -17.5% QoQ
102
50.0% YoY -19.7% QoQ
54
-65.2% YoY -47.1% QoQ
2021 96
-37.7% YoY 77.8% QoQ
101
-20.5% YoY 5.2% QoQ
97
-4.9% YoY -4.0% QoQ
117
116.7% YoY 20.6% QoQ
2022 144
50.0% YoY 23.1% QoQ
85
-15.8% YoY -41.0% QoQ
174
79.4% YoY 104.7% QoQ
236
101.7% YoY 35.6% QoQ
2023 216
50.0% YoY -8.5% QoQ
178
109.4% YoY -17.6% QoQ
324
86.2% YoY 82.0% QoQ
293
24.2% YoY -9.6% QoQ
2024 158
-26.9% YoY -46.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Cabaletta Bio search interestLast update: February 08 2024 17:51:19.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:51:21.

The average 5 years interest of Cabaletta Bio was 11.54 per week.
The last year interest of Cabaletta Bio compared to the last 5 years has changed by 75.13%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 143.79%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DSG3-CAART to provide analysis

Correlation between past revenue and DSG3-CAART search interest

There is not enough data for DSG3-CAART to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DSG3-CAART to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Mucosal pemphigus vulgaris to provide analysis

Correlation between past revenue and Mucosal pemphigus vulgaris search interest

There is not enough data for Mucosal pemphigus vulgaris to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Mucosal pemphigus vulgaris to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for MuSK-CAART to provide analysis

Correlation between past revenue and MuSK-CAART search interest

There is not enough data for MuSK-CAART to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for MuSK-CAART to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CABA-201 to provide analysis

Correlation between past revenue and CABA-201 search interest

There is not enough data for CABA-201 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CABA-201 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PLA2R-CAART to provide analysis

Correlation between past revenue and PLA2R-CAART search interest

There is not enough data for PLA2R-CAART to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PLA2R-CAART to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for DSG3/1-CAART to provide analysis

Correlation between past revenue and DSG3/1-CAART search interest

There is not enough data for DSG3/1-CAART to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for DSG3/1-CAART to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Cabaletta Bio collaboration to provide analysis

Correlation between past revenue and Cabaletta Bio collaboration search interest

There is not enough data for Cabaletta Bio collaboration to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Cabaletta Bio collaboration to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Cabaletta Bio stock price to provide analysis

Correlation between past revenue and Cabaletta Bio stock price search interest

There is not enough data for Cabaletta Bio stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Cabaletta Bio stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 17:51:27.

After 39 days of this quarter the interest is at 105.0. Based on that we can calculate that during remaining 52 days it will total up to 245.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201955
88
60.0% QoQ
201
128.4% QoQ
286
42.3% QoQ
2020 143
160.0% YoY -50.0% QoQ
126
43.2% YoY -11.9% QoQ
204
1.5% YoY 61.9% QoQ
159
-44.4% YoY -22.1% QoQ
2021 97
-32.2% YoY -39.0% QoQ
182
44.4% YoY 87.6% QoQ
142
-30.4% YoY -22.0% QoQ
268
68.6% YoY 88.7% QoQ
2022 172
77.3% YoY -35.8% QoQ
150
-17.6% YoY -12.8% QoQ
164
15.5% YoY 9.3% QoQ
145
-45.9% YoY -11.6% QoQ
2023 206
19.8% YoY 42.1% QoQ
203
35.3% YoY -1.5% QoQ
291
77.4% YoY 43.3% QoQ
342
135.9% YoY 17.5% QoQ
2024 105
-49.0% YoY -69.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Cabaletta Bio -stock -company search interestLast update: February 08 2024 17:51:25.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:51:28.

The average 5 years interest of Cabaletta Bio -stock -company was 14.29 per week.
The last year interest of Cabaletta Bio -stock -company compared to the last 5 years has changed by 41.15%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 61.88%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CABA
Earnings date: 2024-03-14 After close
Company name: Cabaletta Bio Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-15T13:06:16Z

Analyst Upgrades
Wells Fargo Maintains Equal-Weight on Cabaletta Bio, Raises Price Target to $4

2026-05-14T11:05:00Z

GlobeNewswire
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

2026-05-14T11:00:00Z

GlobeNewswire
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

2026-05-04T12:40:48Z

Analyst Upgrades
Cantor Fitzgerald Reiterates Overweight on Cabaletta Bio, Maintains $30 Price Target

2026-05-04T10:35:54Z

GlobeNewswire
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

2026-04-28T12:00:00Z

BusinessWire
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel

2026-04-28T12:00:00Z

GlobeNewswire
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel

2026-04-27T21:00:00Z

GlobeNewswire
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

2026-04-14T20:30:00Z

BusinessWire
First Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform

2026-03-24T13:27:39Z

Analyst Upgrades
Morgan Stanley Maintains Overweight on Cabaletta Bio, Lowers Price Target to $13

2026-03-24T13:20:47Z

Analyst Upgrades
Guggenheim Maintains Buy on Cabaletta Bio, Raises Price Target to $16

2026-03-23T11:30:00Z

GlobeNewswire
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

2026-02-24T13:00:00Z

GlobeNewswire
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference

2026-02-05T13:00:00Z

GlobeNewswire
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

2026-01-12T13:00:00Z

GlobeNewswire
Cabaletta Bio Announces 2026 Strategic Priorities